| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $52.6M | — | +11.2% |
| Cost of Revenue | $10.6M | — | +10.9% |
| Gross Profit | $41.9M | — | +11.3% |
| R&D Expense | $4.2M | — | -7.5% |
| SG&A Expense | $10.0M | — | +0.8% |
| Operating Income | -$5.1M | — | +31.9% |
| Income Tax | $0 | — | — |
| Net Income | -$4.3M | — | +33.8% |
| EPS (Basic) | -$0.10 | — | +33.3% |
| EPS (Diluted) | -$0.10 | — | +33.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $33.5M | -20.6% | -18.6% |
| Accounts Receivable | $31.0M | +3.5% | +15.9% |
| Inventory | $35.5M | +4.8% | +17.0% |
| Current Assets | $214.7M | -0.6% | +5.2% |
| Total Assets | $242.7M | +1.7% | +6.8% |
| Current Liabilities | $21.5M | -15.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.4M | — | +51.9% |
| Capital Expenditures | $1.1M | — | -48.0% |
| Investing Cash Flow | -$6.2M | — | -158.6% |
| Financing Cash Flow | $34K | — | -67.0% |
| Free Cash Flow | -$3.4M | — | +50.8% |
| -10.3% |
| Long-term Debt | $35.6M | +0.1% | +0.3% |
| Total Liabilities | $63.8M | +4.5% | +6.3% |
| Stockholders' Equity | $178.9M | +0.8% | +7.0% |